When The Primary Brain Is Plagued: Diabetes As Predominantly An Intestinal Disease

Amazoniac

Member
Joined
Sep 10, 2014
Messages
8,583
Location
Not Uganda
As you can tell from the title, those are not my words, they're Butcher's (Koch, 1926), and to be more specific, only in obedience to microbial commands, whose cells outnumber ours by a factor of 10. What if there are indeed racialist strains that thrive on skin color rather than their favorable conditions?

- Diabetes is predominantly an intestinal disease

"The connection between gut microbiota and energy homeostasis and low-grade inflammation contribute to dysregulation of normal glucose tolerance. In animals models, altered gut microbiota led to development of obesity, insulin resistance, and diabetes by altered fatty acid metabolism in adipose tissue and liver, modulation of gut peptide YY and glucagon-like peptide (GLP)-1 secretion, activation of the lipopolysaccharide toll-like receptor-4 axis, and modulation of intestinal barrier integrity by GLP-2.[1] Gut bacteria were recently proposed to contribute to differences in body weight, insulin sensitivity, glucose metabolism, and other cardiometabolic risk. A recent study by Karlsson et al., found that the gut microbiome with abundance of particular bacterial species in the gut could differentiate diabetic vs normal glucose tolerant individuals with a degree of accuracy similar to that of traditional predictive models. The bacterial species most predictive of T2D was not consistent across different ethnic groups.[2]"

"Diabetes rapidly resolves following Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion (BPD). A meta-analysis of 136 studies with 22,094 patients demonstrated that T2DM resolved completely in 76.8% and resolved or improved in 86.0% of patients who had undergone bariatric surgery.[8] Complete remission of diabetes occurs in 48% of patients after laparoscopic gastric banding, 84% after RYGB, and 95% after BPD. Diabetes remission after RYGB and BPD is also durable, and recurrence of diabetes 10 years after surgery is rare. RYGB and BPD can cause complete remission of diabetes in days to weeks, long before substantial weight loss; whereas diabetes remission after laparoscopic gastric banding typically occurs over weeks to months, consistent with weight loss.[8]"

"[An hypothesis proposes that] the exclusion of the duodenum and proximal jejunum from the transit of nutrients may prevent secretion of a putative signal that promotes insulin resistance and T2DM."

"Recent experimental studies have suggested the rearrangement of GI anatomy as a primary mediator of the surgical control of diabetes. A study in diabetic Goto-Kakizaki (GK) rats that supports the proximal hypothesis, showed that enhancing delivery of nutrients to the hindgut without excluding nutrient flow through the proximal intestine (via a simple gastrojejunostomy (GJ)) does not improve diabetes.[9] But duodenal-jejunal bypass (DJB), with similar shortcuts of nutrients as in GJ, also includes the exclusion of the proximal intestine from the flow of nutrients, improved glucose tolerance, and fasting glycemia.[9] Glucose intolerance returned when DJB was reversed, even though the GJ was preserved. This experiments shows that the exclusion of the duodenum is critical for the effect on diabetes. However, preventing duodenal passage of nutrients by GI bypass improves glucose tolerance only in patients with diabetes, but is detrimental for glucose homeostasis when performed in nondiabetic humans (i.e. surgical exclusion of the duodenum for the treatment of peptic ulcer or gastric cancer).[8] Therefore, T2DM might be characterized by a component of duodenal-jejunal dysfunction."

"In spite of many patients remaining overweight or frankly obese more than 80 and 90% of RYGB and BPD patients, respectively have a complete sustained remission of T2DM.[10] Consider in terms of its ability to induce disease remission, RYGB (and BPD) appear more effective in treating diabetes than obesity. A recent study showed that changes in the metabolism of the Roux limb itself may play a direct role in the improvement in glucose homeostasis after RYGB by remodeling and reprogramming intestinal glucose disposal and metabolism triggered by exposure of the Roux limb to undigested nutrients.[11]"​

Source of Support: Nil ✓
Conflict of Interest: None declared ✓
Credibility from underdeveloped (and thus uncorrupted) origin: Acceptable ✓
 
Last edited:
OP
Amazoniac

Amazoniac

Member
Joined
Sep 10, 2014
Messages
8,583
Location
Not Uganda
upload_2020-4-11_15-17-3.png

Source: the internet.
 
OP
Amazoniac

Amazoniac

Member
Joined
Sep 10, 2014
Messages
8,583
Location
Not Uganda
- Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota

Abstract said:
Context:
Increasing evidences suggest a correlation between gut and type 1 diabetes (T1D).

Objective:
The objective of this study is to evaluate the gut inflammatory profile and microbiota in patients with T1D compared with healthy control (CTRL) subjects and patients with celiac disease (CD) as gut inflammatory disease controls.

Design/Setting/Participants:
The inflammatory status and microbiome composition were evaluated in biopsies of the duodenal mucosa of patients with T1D (n = 19), in patients with CD (n = 19), and CTRL subjects (n = 16) recruited at San Raffaele Scientific Institute, in Milan, Italy, between 2009 and 2015.

Main Outcome Measures:
Inflammation was evaluated by gene expression study and immunohistochemistry. Microbiome composition was analyzed by 16S ribosomal RNA gene sequencing.

Results:
An increased expression of CCL13, CCL19, CCL22, CCR2, COX2, IL4R, CD68, PTX3, TNFα, and VEGFA was observed in patients with T1D compared with CTRL subjects and patients with CD. Immunohistochemical analysis confirmed T1D-specific inflammatory status compared with healthy and CD control tissues, mainly characterized by the increase of the monocyte/macrophage lineage infiltration. The T1D duodenal mucosal microbiome results were different from the other groups, with an increase in Firmicutes and Firmicutes/Bacteroidetes ratio and a reduction in Proteobacteria and Bacteroidetes. The expression of genes specific for T1D inflammation was associated with the abundance of specific bacteria in the duodenum.

Conclusions:
This study shows that duodenal mucosa in T1D presents disease-specific abnormalities in the inflammatory profile and microbiota. Understanding the mechanisms underlying these features is critical to disentangle the complex pathogenesis of T1D and to gain new perspectives for future therapies targeting the intestine.
 
EMF Mitigation - Flush Niacin - Big 5 Minerals

Similar threads

Back
Top Bottom